Aarti Pharmalabs Ltd - Stock Valuation and Financial Performance

BSE: 543748 | NSE: AARTIPHARM | Pharmaceuticals & Drugs | Small Cap

Aarti Pharmalabs Share Price

764 -16.10 -2.06%
as on 21-Feb'25 16:59

DeciZen - make an informed investing decision on Aarti Pharmalabs

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Aarti Pharmalabs stock performance -

P/E Ratio (SA):
29.91
Market Cap:
6,923.8 Cr.
52-wk low:
380.7
52-wk high:
837

Is Aarti Pharmalabs Ltd an attractive stock to invest in?

1. Is Aarti Pharmalabs Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Aarti Pharmalabs Ltd is a average quality company.

2. Is Aarti Pharmalabs Ltd undervalued or overvalued?

The key valuation ratios of Aarti Pharmalabs Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Aarti Pharmalabs Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Aarti Pharmalabs Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Aarti Pharmalabs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aarti Pharmalabs Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE %
0%0%0%0%0%-8.1%-1.9%18%15.6%16.6%-
Value Creation
Index
NANANANANA-1.6-1.10.30.10.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales
00000009411,5111,5021,657
Sales YoY Gr.
-NANANANANANANA60.6%-0.6%-
Adj EPS
00000-0.8-0.24,268.21922.125.6
YoY Gr.
-NANANANANANANA-99.6%16.6%-
BVPS (₹)
000009.39.149,558.5158.7178.9196.5
Adj Net
Profit
0000000107172200232
Cash Flow from Ops.
0000000-64.8216184-
Debt/CF from Ops.
0000000-511.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA-0.6%
Adj EPS NANANA16.6%
BVPSNANA169.7%12.7%
Share Price - - - 45.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
00000-8.1-216.612.613.113.6
Op. Profit
Mgn %
000000019.120.42323.6
Net Profit
Mgn %
000000011.311.413.314
Debt to
Equity
0000000.10.30.10.2-
Working Cap
Days
0000000163219256132
Cash Conv.
Cycle
000000011615016667

Recent Performance Summary

Sales growth is good in last 4 quarters at 13.22%

Return on Equity has declined versus last 3 years average to 13.60%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Aarti Pharmalabs Ltd.

Standalone Consolidated
TTM EPS (₹) 25.6 27.5
TTM Sales (₹ Cr.) 1,657 2,057
BVPS (₹.) 196.5 213
Reserves (₹ Cr.) 1,735 1,885
P/BV 3.89 3.59
PE 29.91 27.77
From the Market
52 Week Low / High (₹) 380.65 / 837.00
All Time Low / High (₹) 269.00 / 837.00
Market Cap (₹ Cr.) 6,924
Equity (₹ Cr.) 45.3
Face Value (₹) 5
Industry PE 37.5

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 106 5.791.2 5.9103 7.9103 13.9
Adj EPS (₹) 2.6 162.90.8 2.41 7.71 -29.1
Op. Profit Mgn % 9.19 15 bps9.87 -13 bps9.55 -43 bps9.52 -99 bps
Net Profit Mgn % 4.26 254 bps1.63 -6 bps1.69 -1 bps1.71 -91 bps

Management X-Ray of Aarti Pharmalabs:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:44.66%Institutions:19.01%Non-Institutions:36.33%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Mar23Jun23Sep23Dec23Mar24Jun24Sep24Dec240%10%20%30%40%50%
Pledged *0.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Aarti Pharmalabs

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Aarti Pharmalabs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Alembic Pharma 802.8 -10.6 (-1.3%) Small Cap 6,229 30.8 9.6 26.4 3.2
Laurus Labs 521.1 -15.4 (-2.9%) Small Cap 5,041 3.7 3.1 144.5 6.9
Piramal Pharma 208.6 -9.5 (-4.3%) Small Cap 4,390 5.2 8.4 42.1 4.1
Ajanta Pharma 2,607.3 -63.1 (-2.4%) Small Cap 4,209 71.9 19 37.2 8.5
Gland Pharma 1,524.3 3.9 (0.3%) Small Cap 4,167 68.1 24.8 22.3 2.7
Natco Pharma 797.8 4.8 (0.6%) Small Cap 3,999 104.1 34.5 7.6 2
Granules India 509 -18.4 (-3.5%) Small Cap 3,755 13.3 11.7 39.7 3.9
Emcure Pharma 996.8 5.2 (0.5%) Small Cap 3,498 8.5 4.4 116.8 6.5
JB Chem & Pharma 1,605.5 -25 (-1.5%) Small Cap 3,299 40.4 16.1 40.4 7.7
Sanofi India 5,076.8 -91.3 (-1.8%) Small Cap 2,851 184.4 20.8 28 15.5
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24
Sales009411,5111,502
Operating Expenses 007611,2031,156
Manufacturing Costs00202170183
Material Costs00452818752
Employee Cost 0080114120
Other Costs 0027101101
Operating Profit 00180308346
Operating Profit Margin (%) --19.1%20.4%23.0%
Other Income 003111
Interest 00112017
Depreciation 00375666
Exceptional Items 00000
Profit Before Tax 00134233275
Tax 00276274
Profit After Tax 00107172201
PAT Margin (%) --11.3%11.4%13.4%
Adjusted EPS (₹)-0.8-0.24,269.119.022.1
Dividend Payout Ratio (%)0%0%0%11%14%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 001,2391,4391,621
Share Capital 0004545
Reserves 001,2391,3931,576
Minority Interest00000
Debt00325207251
Long Term Debt00000
Short Term Debt00325207251
Trade Payables00132212255
Others Liabilities 00132119170
Total Liabilities 001,8271,9762,297

Fixed Assets

Gross Block001,1011,3041,472
Accumulated Depreciation00400455519
Net Fixed Assets00701848953
CWIP 00187102137
Investments 00405562
Inventories00444538582
Trade Receivables00304372449
Cash Equivalents 005604
Others Assets009361110
Total Assets 001,8271,9762,297

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 00-65216184
PBT 00134233275
Adjustment 00467781
Changes in Working Capital 00-230-38-125
Tax Paid 00-15-57-47
Cash Flow From Investing Activity 00-134-116-184
Capex 00-136-99-146
Net Investments 000-18-48
Others 002110
Cash Flow From Financing Activity 00255-1574
Net Proceeds from Shares 00000
Net Proceeds from Borrowing 00000
Interest Paid 00-11-20-17
Dividend Paid 000-18-18
Others 00266-11839
Net Cash Flow 0056-564
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)N/AN/A17.2312.8313.11
ROCE (%)N/AN/A18.0315.616.55
Asset Turnover Ratio001.030.790.7
PAT to CFO Conversion(x)N/AN/A-0.611.260.92
Working Capital Days
Receivable Days0011882100
Inventory Days00172119136
Payable Days005377113

Aarti Pharmalabs Ltd Stock News

Aarti Pharmalabs Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Aarti Pharmalabs on 21-Feb-2025 16:59 is ₹764.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Feb-2025 16:59 the market cap of Aarti Pharmalabs stood at ₹6,923.8.
The latest P/E ratio of Aarti Pharmalabs as of 21-Feb-2025 16:59 is 29.91.
The latest P/B ratio of Aarti Pharmalabs as of 21-Feb-2025 16:59 is 3.89.
The 52-week high of Aarti Pharmalabs is ₹837.0 and the 52-week low is ₹380.6.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aarti Pharmalabs is ₹1,657 ( Cr.) .

About Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited (APL) (Formerly known as Aarti Organics Limited) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint.

Over the past two decades, enabled by cutting-edge R&D and manufacturing capabilities APL has evolved as a reliable partner of choice for generic players and innovators across the globe. The company specialises in generic APIs, generic intermediates, and xanthine derivatives. It delivers CDMO services for drug substance/NCE development and manufacturing for innovative pharmaceutical and biotech firms with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products.

With the biggest manufacturing capacity in India for its flagship product ‘Caffeine’ APL has emerged as a preferred partner for the Beverages, Nutraceuticals manufacturing companies, and Pharmaceuticals Industries across the world.

Business area of the company

The company is an, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, it integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).

Products and services

  • API
  • Intermediates
  • CDMO Services
  • Caffeine
  • Xanthine Derivatives
  • Acid & Allied

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on